Stocks
Dolby Laboratories (DLB) R&D/CAPEX US GAAP (year values) |
|||||||||
| 2019 | 2020 | 2021 | 2022 | 2022 | LTM ? | CAGR 5 years ? | |||
| R&D/CAPEX, % | 209.5% | 346.5% | 465.8% | 544.9% | 439.3% | 294 776% | |||
| Changes by years, y/y, % | -68pp | +137pp | +119pp | +79pp | -106pp | +14.6% | |||
Dolby Laboratories. R&D/CAPEX, %
Dolby Laboratories. R&D/CAPEX, changes, pp
Dolby Laboratories (DLB) R&D/CAPEX US GAAP (quarter values) |
||||||||
| 2023Q2 | 2023Q2 | 2023Q2 | 2023Q3 | 2023Q4 | LTM ? | |||
| R&D/CAPEX, % | 893.0% | 903.1% | 926.7% | 860.4% | 294 776% | |||
| Changes by years, y/y, % | +364pp | +281pp | ||||||
| Changes by quarters, q/q, % | 0pp | -893pp | +24pp | -66pp | ||||
